Journal list menu
Export Citations
Download PDFs
Gastrointestinal Cancer
Open Access
oa
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence
- First Published: 23 January 2023
Open Access
oa
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
- First Published: 16 January 2023
Open Access
oa
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality
- First Published: 09 November 2022
Open Access
oa
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer
- First Published: 04 November 2022
Open Access
oa
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
- First Published: 03 November 2022
Open Access
oa
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
- First Published: 20 October 2022
Open Access
oa
SDCBP-AS1 destabilizes β-catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
- First Published: 09 October 2022
Open Access
oa
N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA
- First Published: 08 October 2022
Open Access
oa
PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
- First Published: 29 July 2022
Open Access
oa
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
- First Published: 19 July 2022
Open Access
oa
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases
- First Published: 07 July 2022
Open Access
oa
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
- First Published: 05 July 2022
Open Access
oa
Low cholesterol biosynthesis favors epithelial-to-mesenchymal transition maintenance and influences tumor molecular subtyping and disease-free survival in colon cancer patients
- First Published: 30 June 2022
Open Access
oa
PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression
- First Published: 18 June 2022
Open Access
oa
Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates
- First Published: 06 June 2022
Open Access
oa
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer
- First Published: 09 April 2022
Open Access
oa
m6A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels
- First Published: 09 March 2022
Open Access
oa
XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX)
- First Published: 25 February 2022
Open Access
oa
Bone marrow metastasis from advanced gastric cancer complicated with disseminated intravascular coagulation: a highly aggressive but manageable disease subtype
- First Published: 15 February 2022
Open Access
oa
Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies
- First Published: 07 February 2022
Other Gastrointestinal Cancer articles
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
Gunnar Folprecht
Published: 14 November 2019